PATENT CLAIM ANALYSIS

Application Number: 16196217
Application Type: Utility
Filing Date: 2018-11
Publication Date: 2019-03
Patent Classification: ["514", "406000"]

Abstract:
The present application relates to novel compounds of formula (I) to their utility in treating and/or preventing clinical conditions including cardiovascular diseases (CVD), to methods for their therapeutic use, to pharmaceutical compositions containing them and to processes for preparing such compounds.

Claim (Index 1):
A compound according to Formula (I): or a pharmaceutically acceptable salt thereof, wherein: R 1  is H, C 1 -C 3  alkyl, halo, C 1 -C 3  alkoxy, C 1 -C 3  haloalkyl or C 1 -C 3  haloalkoxy; each of R 2  and R 3  is independently H, C 1 -C 3  alkyl, C 1 -C 3  alkoxy, \u2014CN or halo; R 4  is H, \u2014CH 3 , \u2014CH 2 F, \u2014CHF 2 , \u2014CF 3  or halo; Ring A contains 2 double bonds; each X 1 , X 2 , X 3  and X 4  of Ring A is independently CR 5 , CH, O, S, NR 6  or N; wherein at least one of X 1 , X 2 , X 3  and X 4  in Ring A is NR 6 ; each R 5  is optionally and independently C 1 -C 6  alkyl, C 1 -C 6  alkoxy, C 1 -C 3  haloalkyl, C 1 -C 3  haloalkoxy, \u2014S(O) p R 7 , \u2014CN, \u2014CONR\u2032R\u2033, or C 3 -C 6  cycloalkyl; each p is independently 0, 1 or 2; R 6  is H, \u2014CH 3  or \u2014CH 2 CH 3 ; or wherein when X 4  is CR 5  and X 3  is NR 6 , then the R 5  and R 6  may be taken together to form a 5 to 6-membered heterocyclyl ring fused to Ring A, which heterocyclyl may optionally contain an additional heteroatom selected from N, O and S; said fused heterocyclyl may additionally contain a carbonyl or a \u2014S(O) 2  directly adjacent to a heteroatom therein; and may be further substituted with one or two substituents selected from the group consisting of \u2014CH 3  and halo; R 7  is \u2014CH 3  or \u2014NR\u2032R\u2033; and each R\u2032 and R\u2033 is independently \u2014H or \u2014CH 3 ; provided that the total number of substituents on Ring A is 0, 1 or 2; and further provided that when R 5  and R 6  are not combined to form a heterocyclyl ring fused to Ring A, that the total number of R 5  and R 6  substituents which is alkyl and/or haloalkyl is 0 or 1.

Metadata:
- Claim Count in Document: 27.0
- Percentile: 98.0
- Lexical Diversity: 1.26316
- Patent Class: 514.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15571291', '16345016', '14208395', '14584219', '14777492']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.808443280964409
- 35 USC 102 Novelty (BERT): 0.5644212050469887
- Combined Prediction Score: 0.7840410733726669
- Mean Citation Score: 381.063586
- Max Citation Score: 463.3882
- Similarity Product: 325.7249807391882

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test